Plasma YKL-40: A New Potential Marker of Fibrosis in Patients with Alcoholic Cirrhosis?

References

• Friedman S L. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828–35
   PubMed Web of Science ®Google Scholar
• Bissell D M, Friedman S L, Maher J J, Roll F J. Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology 1990; 11: 488–98
   PubMed Web of Science ®Google Scholar
• Iredale J P. Matrix turnover in fibrogenesis (review). Hepato-gastroenterology 1996; 43: 56–71
   PubMedGoogle Scholar
• Johansen J S, Jensen H S, Price P A. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 1993; 32: 949–55
   PubMedGoogle Scholar
• Hakala B E, White C, Recklies A D. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993; 268: 25803–10
   PubMed Web of Science ®Google Scholar
• Hu B, Trinh K, Figueira W F, Price P A. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 1996; 271: 19415–20
   PubMed Web of Science ®Google Scholar
• Coulson A FW. A proposed structure for ‘Family 18’ chitinases. A possible function for narbonin. FEBS Letters 1994; 354: 41–4
   PubMedGoogle Scholar
• Rejman J J, Hurley W L. Isolation and characterization of a novel 39 kilodalton whey protein from bovine mammary secretions collected during the nonlactating period. Biochem Biophys Res Commun 1988; 150: 329–34
   PubMed Web of Science ®Google Scholar
• Johansen J S, Williamson M K, Rice J S, Price P A. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992; 7: 501–12
   PubMed Web of Science ®Google Scholar
• Nyirkos P, Golds E E. Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J 1990; 268: 265–8
   Google Scholar
• Shackelton L M, Mann D M, Millis A JT. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem 1995; 270: 13076–83
   PubMed Web of Science ®Google Scholar
• Morrison B W, Leder P. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and mf-2-initiated tumors. Oncogene 1994; 9: 3417–26
   PubMed Web of Science ®Google Scholar
• Johansen J S, Hansen M, Stoltenberg M, Florescu A, Horslev-Petersen K, Price P A. Does serum YKL-40 reflect inflammatory and disease activity in rheumatoid arthritis?. XHIth European Congress of Rheumatology (EULAR), AmsterdamThe Netherlands, June, 1995, Abstract D158B
   Google Scholar
• Johansen J S, Hvolris J, Hansen M, Backer V, Lorenzen I, Price P A. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 1996; 35: 553–9
   PubMedGoogle Scholar
• Johansen J S, Stoltenberg M, Hansen M, Hansen T M, Price P A, Gøtzsche P C. Serum YKL-40 reflects disease relapse after withdrawal of SAARD in patients with rheumatoid arthritis. ACR 60th National Scientific Meeting, OrlandoUSA, October, 1996, Abstract 768
   Google Scholar
• Volck B, Johansen J S, Stoltenberg M, Østergaard M, Price P A, Lorenzen I. Serum YKL-40 reflects pharmacological induced reduction of synovial inflammation of the knee joint in patients with rheumatoid arthritis. ACR 60th National Scientific Meeting, OrlandoUSA, October, 1996, Abstract 769
   Google Scholar
• Johansen J S, Cintin C, Jorgensen M, Kamby C, Price P A. Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer 1995; 31A: 1437–42
   PubMed Web of Science ®Google Scholar
• Gluud C. Copenhagen study group for liver diseases. Serum testosterone concentrations in men with alcoholic cirrhosis: background for variation. Metabolism 1987; 36: 373–8
   PubMed Web of Science ®Google Scholar
• Junge J, Horn T, Christoffersen P. The occurrence and significance of fibronectin in livers from chronic alcoholics. APMIS 1988; 96: 56–61
   PubMedGoogle Scholar
• Henriksen J H. Variability of hydrostatic hepatic vein and ascitic fluid pressure and of plasma and ascitic fluid colloid osmotic pressure in patients with liver cirrhosis. Scand J Clin Lab Invest 1980; 40: 515–22
   PubMed Web of Science ®Google Scholar
• Henriksen J H, Ring-Larsen H, Kanstrup I-L, Christensen N J. Splanchnic and renal elimination and release of catecholamines in cirrhosis: evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis. Gut 1984; 25: 1034–43
   PubMed Web of Science ®Google Scholar
• Henriksen J H, Winkler K. Hepatic blood flow determination: a comparison of 99mTc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man. J Hepatol 1987; 4: 66–70
   PubMed Web of Science ®Google Scholar
• Tygstrup N. Determination of the hepatic galactose elimination capacity after a single intravenous injection and the influence of uneven distribution. Acta Physiol Scand 1963; 58: 162–9
   PubMedGoogle Scholar
• Risteli J, Nicmi S, Trivedi P, Maentausta O, Mowat A P, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715–8
   PubMed Web of Science ®Google Scholar
• Mathew J, Geerts A, Burt A D. Pathobiology of hepatic stellate cells (review). Hcpatogastroenterology 1996; 43: 72–91
   PubMedGoogle Scholar
• Bentsen K D, Horn T, Risteli J, Risteli L, Engström-Laurent A, Hørslev-Petersen K, et al. Serum aminoterminal type ill procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to scrum hyaluronan. Liver 1987; 7: 339–46
   PubMedGoogle Scholar
• Ramadori G, Zöhrens G, Manns M, Riedcr H, Dienes H P, Hess G, et al. Scrum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 1991; 21: 323–30
   PubMed Web of Science ®Google Scholar
• Rosman A S, Licber C S. Diagnostic utility of laboratory tests in alcoholic liver disease. Clin Chem 1994; 40: 1641–51
   PubMed Web of Science ®Google Scholar
• Pares A, Deulofeu R, Gimencz A, Caballeria L, Bruguera M, Caballeria J, et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996; 24: 1399–403
   PubMedGoogle Scholar
• Beeuwkes R, Ichikawa I, Brenner M B. The renal circulation. The kidney, B M Brenner, F C Rector. W. B. Saunders Company, Philadelphia 1981; Vol. 1: 249–88
   Google Scholar